Interleukin-6 is a mediator of therapeutic efficacy in acute lung injury

Journal:
American Journal of Respiratory and Critical Care Medicine
Published:
DOI:
10.1093/ajrccm/aamag213
Affiliations:
6
Authors:
10
Go to article
Institutions Authors Share
Amsterdam UMC, Netherlands
5.000000
 0.50
Queen's University Belfast (QUB), United Kingdom (UK)
2.000000
 0.20
National and Kapodistrian University of Athens (UOA), Greece
2.000000
 0.20
UCSF Health, United States of America (USA)
1.000000
 0.10
Interested in Immunology?